| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| INSMED Inc | Chief Financial Officer | Common Stock | 117K | $5.87M | $50.00 | May 29, 2024 | Direct |
| INSMED Inc | Chief Financial Officer | Stock Option (right to buy) | 59.4K | $1.22M | $20.49 | May 29, 2024 | Direct |
| Xilio Therapeutics, Inc. | Director | Stock Option (right to buy) | 25K | Jun 14, 2024 | Direct | ||
| scPharmaceuticals Inc. | Director | Stock Option (Right to Buy) | 19.8K | Jun 11, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| XLO | Xilio Therapeutics, Inc. | Jun 14, 2024 | 1 | $0 | 4 | Jun 17, 2024 | Director |
| SCPH | scPharmaceuticals Inc. | Jun 11, 2024 | 1 | $0 | 4 | Jun 13, 2024 | Director |
| INSM | INSMED Inc | May 28, 2024 | 26 | -$5.66M | 4 | May 30, 2024 | Chief Financial Officer |
| INSM | INSMED Inc | May 13, 2024 | 3 | -$281K | 4 | May 15, 2024 | Chief Financial Officer |
| INSM | INSMED Inc | Jan 9, 2024 | 1 | -$131K | 4 | Jan 11, 2024 | Chief Financial Officer |
| INSM | INSMED Inc | Jan 4, 2024 | 2 | $0 | 4 | Jan 5, 2024 | Chief Financial Officer |
| INSM | INSMED Inc | Dec 22, 2023 | 1 | -$396K | 4 | Dec 22, 2023 | Chief Financial Officer |
| XLO | Xilio Therapeutics, Inc. | Jun 12, 2023 | 1 | $0 | 4 | Jun 13, 2023 | Director |
| SCPH | scPharmaceuticals Inc. | Jun 6, 2023 | 1 | $0 | 4 | Jun 8, 2023 | Director |
| INSM | INSMED Inc | May 15, 2023 | 2 | -$72.4K | 4 | May 17, 2023 | Chief Financial Officer |
| INSM | INSMED Inc | May 11, 2023 | 3 | $0 | 4 | May 15, 2023 | Chief Financial Officer |
| INSM | INSMED Inc | Jan 10, 2023 | 1 | -$51.8K | 4 | Jan 12, 2023 | Chief Financial Officer |
| INSM | INSMED Inc | Jan 5, 2023 | 3 | $0 | 4 | Jan 6, 2023 | Chief Financial Officer |
| XLO | Xilio Therapeutics, Inc. | Jun 15, 2022 | 1 | $0 | 4 | Jun 17, 2022 | Director |
| SCPH | scPharmaceuticals Inc. | Jun 14, 2022 | 1 | $0 | 4 | Jun 15, 2022 | Director |
| INSM | INSMED Inc | May 16, 2022 | 1 | -$26.5K | 4 | May 18, 2022 | Chief Financial Officer |
| INSM | INSMED Inc | May 11, 2022 | 2 | $0 | 4 | May 13, 2022 | Chief Financial Officer |
| INSM | INSMED Inc | Jan 11, 2022 | 1 | -$29K | 4 | Jan 13, 2022 | Chief Financial Officer |
| INSM | INSMED Inc | Jan 6, 2022 | 2 | $0 | 4 | Jan 10, 2022 | Chief Financial Officer |
| XLO | Xilio Therapeutics, Inc. | Oct 21, 2021 | 0 | $0 | 3 | Oct 21, 2021 | Director |
| SCPH | scPharmaceuticals Inc. | Jun 8, 2021 | 1 | $0 | 4 | Jun 10, 2021 | Director |
| INSM | INSMED Inc | May 12, 2021 | 2 | $0 | 4 | May 14, 2021 | Chief Financial Officer |